Abstract: Medical data analysis is increasingly used to plan, improve research techniques, and explain diagnoses. The allocation of medical resources is based on the prevalence of specific pathologies ...

During her conversation with PEOPLE, Krakow was asked about how things would unfold now that Nathan would be living with Charlotte in Cape Fullerton. In response, the Army Wives alum revealed that ...

Edgewise Therapeutics (EWTX) added ~17% on Wednesday after the Boulder, Colorado-based biopharma updated data from a mid-stage trial for EDG-7500, its experimental therapy for a genetic heart disorder ...

There is increasing evidence that gum disease is associated with increased risk of cardiovascular events, including heart attack, stroke, atrial fibrillation, heart failure and cardiometabolic health ...

The Biden administration withheld data from the public on the risks of myocarditis from the Covid vaccine, Food and Drug Administration Commissioner Marty Makary claimed Thursday — a bold accusation ...

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

A few days ago, we looked into how Apple could one day use brain wave sensors in AirPods to measure sleep quality and even detect seizures. Now, a new paper shows how the company is exploring deeper ...

This study proposes an important new approach to analyzing cell-count data, which are often undersampled and cannot be accurately assessed using traditional statistical methods. The case studies ...

The Nvidia-backed data center company is part of a growing ecosystem of so-called neoclouds propping up the AI industry and its insatiable hunger for compute. The Nvidia-backed data center company is ...

Andrew Wang, M.D., Cardiologist and Professor of Medicine, Duke University School of Medicine presented a pre-specified responder analysis from MAPLE-HCM evaluating five clinically relevant measures ...

Oral Presentation on Saturday to Highlight Interim Safety and Efficacy Results from the MyPEAK™-1 Phase 1b/2a Clinical Trial in Adults with MYBPC3-Associated Hypertrophic Cardiomyopathy Second ...